Real-time fundus images captured to detect multiple diseases are prone to different quality issues like illumination, noise, etc., resulting in less visibility of anomalies. So, enhancing the retinal fundus images is essential for a better prediction rate of eye diseases. In this paper, we propose Lab color space-based enhancement techniques for retinal image enhancement. Existing research works does not consider the relation between color spaces of the fundus image in selecting a specific channel to perform retinal image enhancement. Our unique contribution to this research work is utilizing the color dominance of an image in quantifying the distribution of information in the blue channel and performing enhancement in Lab space followed by a series of steps to optimize overall brightness and contrast. The test set of the Retinal Fundus Multi-disease Image Dataset is used to evaluate the performance of the proposed enhancement technique in identifying the presence or absence of retinal abnormality. The proposed technique achieved an accuracy of 89.53 percent.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156681 | PMC |
http://dx.doi.org/10.1038/s41598-023-34212-w | DOI Listing |
Sci Rep
December 2024
Department of Ophthalmology, University of Health Sciences, Antalya Education and Research Hospital, Antalya, 07050, Turkey.
Our current prospective cross-sectional study aimed to investigate the effect of anti-vascular endothelial growth factor (VEGF) drugs used in the treatment of retinopathy of prematurity on retinal maturation and persistent avascular retina (PAR). Retinal imaging was performed with Optos confocal laser ophthalmoscopy for 100 patients aged 4 to 8 years who were screened and treated for retinopathy of prematurity (ROP) during the neonatal period. The ROP examination findings (stage and zone) and treatment history (age in weeks at time of treatment and anti-VEGF drug used) from the neonatal period were reviewed.
View Article and Find Full Text PDFArch Soc Esp Oftalmol (Engl Ed)
December 2024
Servicio de Oftalmología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.
Photodiagnosis Photodyn Ther
December 2024
Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin, China, Ministry of Education International Joint Laboratory of Ocular Diseases, Tianjin, China, Tianjin Key Laboratory of Ocular Trauma, Tianjin, China, Tianjin Institute of Eye Health and Eye Diseases, Tianjin, China, China-UK "Belt and Road" Ophthalmology. Electronic address:
Background: This study investigated the association between photoreceptor structural restoration and visual function outcomes in patients undergoing surgery for closed macular holes (MHs). Using adaptive optics scanning laser ophthalmoscopy (AOSLO) and microperimetry, we aimed to provide a more detailed understanding of photoreceptor recovery and visual improvement in closed MHs.
Methods: We conducted a retrospective observational study of 31 eyes of 28 patients who underwent vitrectomy with internal limiting membrane (ILM) peeling to treat idiopathic MHs.
Comput Biol Med
December 2024
Khalifa University, Abu Dhabi, United Arab Emirates.
Background And Objective: Accurate extraction of retinal vascular components is vital in diagnosing and treating retinal diseases. Achieving precise segmentation of retinal blood vessels is challenging due to their complex structure and overlapping vessels with other anatomical features. Existing deep neural networks often suffer from false positives at vessel branches or missing fragile vessel patterns.
View Article and Find Full Text PDFClin Exp Ophthalmol
December 2024
The Save Sight Institute, Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia.
Background: We aimed to describe a 2-year outcome of eyes managed by practitioners benchmarked using a funnel plot by their frequency of treatment using vascular endothelial growth factor (VEGF) inhibitors for naive retinal vein occlusion (RVO).
Methods: A multicentre, international, observational study of 29 doctors in 12 countries managing 1110 eyes with RVO commencing VEGF inhibitors between 1 January 2012-2022 tracked in the Fight Retinal Blindness! registry.
Results: We identified 3 outlying 'intensive' practitioners (managing 350/1110 eyes [32%]), 22 'typical' practitioners (604/1110, [54%]) and 4 outlying 'relaxed' practitioners (156/1110, [14%]) with respective 24-month outcomes in Branch and Central RVO including the primary outcome, mean adjusted change in visual acuity (VA) in BRVO: +16.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!